Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349(9055):825–32.
2. World Health Organization. Guideline for the screening, care and treatment of persons with hepatitis infection. 2014.
http://apps.who.int/iris/bitstream/10665/111747/1/9789241548755_eng.pdf?ua=1
. Accessed 12 Sept 2014.
3. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med. 2002;347(13):975–82.
4. American Association for the Study of Liver Diseases and the Infectious Diseases Society of America. Recommendations for testing, managing, and treating hepatitis C. 2014.
http://www.hcvguidelines.org/
. Accessed 10 Aug 2014.
5. Fouad YM. Chronic hepatitis C-associated thrombocytopenia: aetiology and management. Trop Gastroenterol. 2013;34(2):58–67.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献